Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos

"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos. The invention relates to the use of cilansetron for treating non-obst...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	STEVEN DAVID CARAS, WERNER CAUTREELS, CLAUS RUDOLF STEINBORN, ALBERTUS HERMANNUS DIRK PLEKKENPOL, EGBERTUS HENDRIKUS EVERT BIESHEUVEL, HEINZ GUENTER KRAUSE
Format:	Patent
Sprache:	por
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos. The invention relates to the use of cilansetron for treating non-obstipated male IBS patients and also for treating patients of both sexes, who suffer from irritable bowel syndrome (IBS), by administering the pharmaceutical preparation three times a day. In said preparation, alosetron, azasetron, dolasetron, granisetron, indisetron, itasetron, lerisetron, ondansetron, ramosetron, tropisetron, and/or (R)-zacopride are used as 5HT3 receptor antagonists.